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ABSTRACT	  
	  
Purpose.	   The	  main	   end	   point	   of	   the	   study	  was	   to	   compare	   the	   surgical	   performance	   of	   robot-­‐
assisted	  pulmonary	   lobectomy	  with	  open	   (thoracotomy)	   lobectomy	   for	  clinical	   stage	   I	   (T1a	  N0	  –	  
T2a	  N0;	   T	  <5	   cm)	  non-­‐small	   cell	   lung	   cancer	   (NSCLC).	   Secondary	  end	  points	  were	  description	  of	  
short	   and	   mid-­‐term	   clinical	   outcomes	   of	   the	   robotic	   procedure,	   in	   particular	   in	   terms	   of	   pain	  
perception	  and	  quality	  of	  life.	  
Methods.	   A	   retrospective	   analysis	   of	   prospectively	   collected	   data	   was	   performed,	   concerning	  
totally	  endoscopic	  robotic	  lobectomies	  (RL)	  performed	  between	  January	  2011	  and	  December	  2013	  
on	  86	  patients	   for	  Stage	   I	  NSCLC.	  The	  robotic	  procedures	  were	  conducted	  employing	  a	   four-­‐arm	  
robotic	   device	   (Da	   Vinci	   Robotic	   System)	   through	   a	   five	   port	   minimally	   invasive	   access	   (a	   fifth	  
utility	  port	  was	  needed	  for	  insertion	  of	  suction	  devices	  and	  gauze	  placement).	  After	  lobectomy,	  a	  
systematic	   lymphadenectomy	   was	   performed	   in	   all	   cases.	   The	   surgical	   outcomes	   were	  
subsequently	  compared	  to	  a	  cohort	  of	  160	  patients	  who	  afforded	  standard	  “open”	  lobectomy	  (OL)	  
in	  the	  same	  period,	  and	  the	  data	  were	  matched	  to	  the	  robotic	  group	  using	  propensity	  scores	  for	  a	  
series	  of	  pre-­‐determined	  preoperative	  variables.	  
Results.	  Clinical	  and	  pathologic	  characteristics	  were	  similar	  between	  the	  two	  groups.	  Conversion	  
from	  robotic	  to	  open	  surgery	  was	  necessary	  in	  4	  cases.	  Median	  operating	  time	  was	  168	  min	  (110	  –	  
308	  min)	  for	  robotic	  procedures	  and	  122	  min	  (97	  –	  145	  min)	  for	  open	  procedures.	  Median	  number	  
of	   lymph	   nodes	   removed	   and	   rate	   of	   major	   complication	   were	   similar	   in	   the	   2	   groups.	   Pain	  
perception	   in	   the	   first	   three	   post-­‐operative	   days	   was	   significantly	   lower	   in	   the	   robotic	   cohort.	  	  
Median	  postoperative	  drainage	  and	  hospitalization	  time	  were	  similar	  between	  two	  groups.	  Quality	  
of	   life,	   determined	  by	   the	  Short	   Form	  Health	   Survey	   (SF	  12),	  was	  evaluated	  after	  4	  weeks	   from	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surgery.	  A	  better	  average	  mental	  and	  physical	  health	  perception	  was	  evidenced	  in	  the	  RL	  group	  as	  
compared	  to	  OL	  (Mental:	  56.2	  vs	  39,	  p	  =	  0.01;	  Physical	  43.8	  vs	  32.1,	  p	  =	  0.04).	  	  
Conclusions.	  Robotic	  lobectomy	  with	  lymph	  node	  dissection	  for	  clinical	  stage	  I	  lung	  cancer	  proved	  
to	  be	  equal	  to	  open	  lobectomy	  in	  terms	  of	  surgical	  performance.	  Furthermore,	  robotic	  approach	  
allows	  a	  faster	  recovery	  with	  a	  long	  lasting	  limitation	  of	  pain	  perception,	  improvement	  of	  quality	  
of	  life	  and	  faster	  return	  to	  the	  preoperative	  activity	  level.	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INTRODUCTION	  
Lobectomy,	   achieved	   both	   trough	   a	   thoracotomic	   or	  minimally	   invasive	   approach	   is	   the	  
treatment	  of	  choice	  for	  both	  early	  and	  locally	  advanced	  non-­‐small	  lung	  cancer	  [1,	  2].	  A	  rapid	  shift	  
from	  “classic”	  thoracotomic	  approach	  to	  minimally	   invasive	  techniques	  for	   lobectomy	  took	  place	  
in	   the	   last	   decade,	   and	   Video-­‐assisted	   thoracic	   surgery	   (VATS)	   Lobectomy	   became	   the	   gold	  
standard	  in	  the	  treatment	  of	  stage	  I	  and	  even	  stage	  II	  NSCLC	  [3,	  4].	  It	  displays	  several	  advantages,	  
first	  of	  all	  a	  minor	  degree	  of	  tissue	  trauma,	  with	  less	  post-­‐surgical	  pain	  and	  faster	  recovery	  for	  the	  
patients	  [5,	  6].	  Robotic	  surgical	  systems	  may	  facilitate	  major	  lung	  resections	  in	  a	  minimally	  invasive	  
setting.	  In	  particular,	  the	  robotic	  device	  allows	  three	  dimensional	  vision	  and	  magnification	  of	  the	  
surgical	   field	   and	   an	   incremented	  manoeuvrability	   of	   the	   instruments,	   given	   their	   7-­‐degrees	   of	  
freedom	  [7].	  The	  number	  of	  operative	  series	  progressively	  incremented	  over	  time,	  confirming	  the	  
safety	  and	  feasibility	  of	  robotic	  lobectomy	  in	  the	  treatment	  of	  early	  stage	  NSCLC	  and	  its	  oncologic	  
results	   [8].	  We	  decided	   to	   compare	   robotic	   lobectomy	   (RL)	   to	   standard	  open	   lobectomy	   (OL)	   in	  
order	   to	   directly	   identify	   the	   possible	   advantages	   of	   this	   technology	   over	   conventional	   open	  
surgery.	  We	  therefore	  designed	  a	  nonrandomized,	  controlled	  trial	  with	  adequate	  number	  of	  cases	  
in	  order	  to	  better	  define	  the	  surgical	  performance	  of	  the	  robotic	  device,	  in	  terms	  of	  surgical	  time,	  
number	  of	  lymph	  nodes	  removed,	  perioperative	  complications,	  drainage	  and	  hospitalization	  time,	  
long	   term	   complications	   and	   impact	   on	   quality	   of	   life,	   in	   comparison	  with	   a	  matched	   group	   of	  
patients	   with	   similar	   clinicopathologic	   features	   who	   underwent	   standard	   lobectomy.	   Data	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MATERIAL	  AND	  METHODS	  
A	   retrospective	   analysis	   of	   prospectively	   collected	   data	   from	   January	   2011	   to	   December	  
2013	   was	   performed	   on	   144	   patients	   subjected	   to	   robot-­‐assisted	   lobectomy.	   Inclusion	  
characteristics	  for	  this	  study	  were:	  
• Diagnosis	  of	  NSCLC	  
• Clinical	  Stage	  I	  	  
• Age	  <75	  years,	  
• Eastern	  Cooperative	  Oncology	  Group	  (ECOG)	  Performance	  status	  0-­‐1,	  
• Adequate	   pulmonary	   function	   (Forced	   expiratory	   volume	   in	   1	   second	   >60%,	  
Diffusion	  of	  Carbon	  Monoxide	  >80%;	  maximal	  oxygen	  consumption	  (VO2	  max)	  >18	  
ml/kg/min),	  
• American	  Society	  of	  Anaesthesiologists	  (ASA)	  score	  1	  to	  3.	  
Only	  clinical	   stage	   I	   tumors	   (cT1a	  N0	  –	  cT2a	  N0)	  were	   included;	   in	  particular	  we	  selected	  
only	  tumors	  with	  a	  diameter	  <5	  cm,	  without	  involvement	  of	  chest	  wall	  and/or	  mediastinum	  and/or	  
diaphragm,	  main	  bronchus,	   and	  without	  overt	   lymph	  node	  metastases.	  We	   limited	   the	   study	   to	  
clinical	  Stage	  I	  NSCLC	  because	  in	  the	  first	  year	  of	  the	  study	  period	  (2011),	  the	  use	  of	  the	  robot	  was	  
limited	   to	   this	   setting	   of	   patients,	   although	   in	   the	   subsequent	   years	   the	   robotic	   approach	   was	  
employed	  in	  more	  advanced	  stages.	  Patients	  of	  the	  robotic	  group	  were	  selected	  and	  operated	  by	  a	  
single	  surgeon	  proficient	  in	  robotic	  surgery.	  All	  patients	  underwent	  complete	  preoperative	  staging	  
and	  complete	  functional	  evaluation.	   In	  particular,	  PET-­‐CT	  scan	  was	  performed	  on	  a	  routine	  basis	  
and	  suspect	  lymph	  nodal	  involvement	  was	  ruled	  out	  with	  trans	  bronchial	  needle	  aspiration	  (TBNA)	  
	   6	  
and	   mediastinoscopy	   when	   needed.	   Functional	   evaluation	   included	   complete	   spirometric	  
evaluation	  with	  diffusion	  of	  Carbon	  Monoxide	  (DLCO)	  and	  ergospirometry	  when	  required.	  
In	   the	   study	  period,	   86	   patients	   fulfilling	   the	   inclusion	   criteria	  were	   selected.	  A	   separate	  
cohort	  of	  patients	  subjected	  to	  lobectomy	  through	  thoracotomy	  (open	  lobectomy,	  OL)	  with	  similar	  
characteristics	   was	   defined	   employing	   propensity	   scores,	   a	   quasi-­‐randomization	   method	   which	  
allows	  group	  of	  patients	   to	  be	  well	  matched	  and	   to	  undergo	  proper	  performance	  and	  outcome	  
comparison	  (see	  statistical	  analysis).	  During	  the	  study	  period	  a	  total	  of	  467	  open	  lobectomies	  have	  
been	  performed.	   From	   these,	  160	  procedures	   fulfilled	   the	  predefined	   criteria	   for	  matching	  with	  
the	   robotic	   procedures.	   Robotic	   approach	   was	   chosen	   on	   a	   non-­‐randomized	   fashion,	   basing	  
primarily	   on	   limited	   availability	   of	   the	   robot	   (1	   or	   2	   times	   a	  week),	   given	   the	   rotation	   of	   other	  
specialities	  on	  the	  same	  machine,	  and	  the	  presence	  of	  only	  one	  surgeon	  familiar	  with	  the	  robotic	  
device.	  
Surgical	  performance	  parameters	  
The	  following	  were	  considered	  surgical	  performance	  parameters:	  number	  of	  lymph	  nodes	  
removed,	   nodal	   upstaging,	   surgical	   margin	   positivity,	   operative	   time	   (minutes),	   need	   for	   blood	  
transfusion,	   post-­‐operative	   (30	   days)	   complications.	   Complication	   magnitude	   was	   defined	  
according	  to	  Clavien-­‐Dindo	  Classification	  [9].	  Minor	  complication	  requires	  no	  further	  (Grade	  I)	  or	  
minimal	   treatment	   (Grade	   II).	   Major	   complication	   requires	   surgical,	   radiologic,	   endoscopic	  
intervention	  (grade	  III)	  or	  intensive	  care	  unit	  management	  and	  life	  support	  (grade	  IV).	  	  Operative	  
time	  was	  considered	  from	  skin	  incision	  to	  closure,	  and	  included	  frozen	  section	  examination	  when	  
needed.	  Operative	  time	  included	  also	  the	  time	  needed	  for	  positioning	  the	  surgical	  cart	  and	  robot	  
arms	  in	  the	  surgical	  field	  (docking	  time).	  
	  
	   7	  
Outcome	  parameters	  
Post	   operative	   pain	   perception,	   duration	   of	   chest	   drainage,	   hospitalization	   time,	   time	   to	  
return	  to	  preoperative	  level	  of	  activity	  or	  status	  were	  evaluated.	  Pain	  perception	  was	  assessed	  in	  
the	  first	  three	  days	  and	  then	  once	  a	  week	  in	  the	  first	  three	  weeks,	  using	  the	  Verbal	  Numeric	  Rating	  
Scale	  (VNRS).	  Pain	  was	  then	  evaluated	  as	  part	  of	  the	  quality	  of	   life	  assessment	  (see	   later).	  Chest	  
tubes	   were	   removed	   in	   absence	   of	   air	   leak	   for	   at	   least	   24	   hours,	   or	   when	   daily	   drainage	   was	  
inferior	  to	  300	  ml.	  Return	  to	  a	  “normal	  activity	  status”	  (working	  activity)	  was	  assessed	  by	  means	  of	  
direct	  interview	  of	  the	  patient	  after	  about	  one	  month	  from	  intervention	  and	  was	  described	  as	  >	  or	  
<	   of	   28	   days.	   Quality	   of	   life	   was	   defined	   by	   a	   Short	   Form	   Health	   Survey	   (SF	   12)	   method,	   a	  
widespread	   method	   for	   quality	   of	   life	   assessment	   in	   adult	   populations	   	   [10,	   11].	   The	   survey	  
describes	   both	   the	   physical	   and	   mental	   health	   status	   basing	   on	   four	   scales	   for	   the	   physical	  
component	   summary	   (PCS:	  Physical	   Functioning,	  Role-­‐Physical,	   Bodily	  pain,	  General	  Health)	   and	  
mental	   component	   summary	   (MCS:	   Vitality,	   Social	   Functioning,	   Role-­‐Emotional,	  Mental	  Health).	  
The	   survey	   was	   completed	   preoperatively,	   after	   four	   weeks	   and	   finally	   after	   five	  months	   from	  
surgery.	   Data	   were	   acquired	   basing	   on	   telephonic	   interview	   or	   during	   outpatient	   clinical	  
evaluation.	  
Robotic	  Lobectomy	  
All	   patients	   signed	   an	   informant	   consent	   to	   undergone	   lobectomy.	   The	   technique	   of	  
robotic	  assisted	  lobectomy	  has	  been	  previously	  described	  in	  detail	  [6].	  A	  four	  arm	  robotic	  device	  
with	   high	   definition	   magnified	   3D	   vision	   was	   employed	   in	   all	   cases.	   The	   patient,	   after	   general	  
anaesthesia	  and	  double	   lumen	   tube	   intubation	  was	  placed	   in	   lateral	  decubitus,	   and	   the	   surgical	  
cart	  of	   the	   robotic	   system	  was	  placed	  at	   the	  head	  of	   the	  patient.	  Four	   incisions	  allowed	  robotic	  
arm	  positioning	  (Figure	  1).	  The	  first	  port	  was	  placed	  in	  the	  seventh	  or	  eighth	  inter-­‐costal	  space	  on	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the	  middle	  axillary	  line	  for	  the	  camera	  (12	  mm,	  30°	  angled	  down	  scope).	  The	  other	  port	  incisions	  (8	  
mm)	  were	  performed	   in	  the	   fifth	  or	  sixth	   inter-­‐costal	  space	  on	  the	  anterior	  axillary	   line,	  sixth	  or	  
seventh	  inter-­‐costal	  space	  on	  the	  posterior	  axillary	  line	  and	  in	  the	  auscultatory	  area	  (for	  the	  fourth	  
arm).	   A	   utility,	   8	   mm	   port	   between	   the	   camera	   port	   and	   the	   anterior	   robotic	   port	   can	   be	  
positioned	   to	   allow	   stapler	   or	   suction	   devices	   insertion	   by	   the	   assistant	   surgeon.	   In	   absence	   of	  
preoperative	  diagnosis,	   the	   lesion	  was	   identified	  and	   resected	  with	  a	   robotically-­‐assisted	  wedge	  
resection,	  and	  frozen	  section	  analysis	  was	  performed.	  Dissection	  started	  at	  the	  level	  of	  pulmonary	  
ligament	   and	   continued	   on	   the	   anterior	   hilum,	   employing	   Cadiere	   forceps	   and	   cautery	   hook.	  
Vascular	   structures	  were	   isolated,	  and,	  as	  a	  general	   rule,	  arteries	  were	   ligated	  prior	   to	  veins,	   to	  
avoid	   lung	   congestion.	   For	   vascular	   ligation,	   plastic	   clips	   (Hem-o-lok®,Teleflex Medical, Research 
Triangle Park, NC),	  or	  direct	  suturing	  with	  linen	  was	  preferred	  to	  stapler	  because	  it	  resulted	  a	  more	  
time-­‐saving	   approach	   than	   positioning	   a	   stapling	   device	   by	   the	   assistant	   surgeon.	   Veins	   and	  
bronchi	   were	   sutured	   with	   endostaplers.	   Hilar	   and	  mediastinal	   dissection	   was	   performed	   after	  
lobectomy	  with	  removal	  of	  lymph	  nodes	  at	  station	  9,	  7,	  10,	  4R	  and	  2R	  on	  the	  right	  and	  at	  station	  9,	  
7,	  6	  and	  5	  on	  the	  left	  (station	  4L	  was	  not	  routinely	  dissected).	  
Statistical	  analysis	  
A	  greedy	  algorhytm	  was	  employed	  to	  create	  a	  cohort	  of	  propensity	  score	  matched	  patients	  
with	   similar	   characteristics	   to	   the	   robotic	   lobectomy	   group	   for	   a	   given	   number	   of	   preoperative	  
characteristics,	  as	  described	  in	  Table	  1.	  Propensity	  scores	  were	  used	  to	  avoid	  the	  bias	  of	  the	  lack	  of	  
randomization	   between	   the	   two	   groups	   [5].	   Therefore,	   a	   group	   of	   160	   open	   lobectomies	   was	  
selected.	  Logistic	   regression	  analysis	  was	  used	   to	   identify	  covariates	  among	  the	  baseline	  patient	  
variables	   that	   were	   imbalanced	   between	   the	   two	   groups	   from	   which	   the	   model	   was	   derived.	  
Resulting	   matched	   patients	   were	   analysed	   for	   differences	   in	   selected	   intraoperative	   and	  
postoperative	   outcomes.	   Pearson’s	   χ2	   test	   was	   used	   to	   calculate	   the	   probability	   value	   for	   the	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comparison	  of	  dichotomous	  variables.	  Fisher’s	  exact	   test	  was	  used	  when	  the	  number	   in	  any	  cell	  
was	  less	  than	  five.	  Statistical	  and	  mathematical	  models	  were	  created	  and	  analysed	  using	  Wolfram	  
Mathematica	  8.0	  (Wolfram	  Mathematica	   is	  a	  computational	  software	  program	  used	   in	  scientific,	  
engineering	   and	   mathematical	   fields	   and	   other	   areas	   of	   technical	   computing.	   See	  
http://www.wolfram.com/).
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RESULTS	  
Clinicopathologic	  characteristics	  
At	   the	   end	   of	   the	   study	   period	   (January	   2011-­‐December	   2013),	   86	   patients	   underwent	   robotic	  
lobectomy	   for	   clinical	   Stage	   I	   NSCLC.	   Conversion	   thoracotomy	   was	   needed	   in	   4	   cases:	   in	   3	   for	  
adhesions	   and	   in	   1	   to	   allow	   safer	   isolation	   of	   vascular	   structures	   in	   presence	   of	   calcified	   hilar	  
lymph	  nodes.	  No	  major	   intraoperative	  bleeding	  requiring	  emergent	  conversion	  occurred.	  Patient	  
characteristics	   are	   summarized	   in	   table	   1.	   The	   robotic	   lobectomy	   group	   was	   matched	   with	   a	  
cohort	  of	  patients	  with	  overlapping	  characteristics,	  who	  underwent	  thoracotomic	  lobectomy.	  The	  
robotic	  group	  was	  composed	  by	  26	  right	  upper	  lobectomies,	  7	  middle	  lobe	  lobectomies,	  15	  right	  
lower	   lobectomies,	   24	   left	   upper	   lobectomies,	   14	   left	   lower	   lobectomies.	   Distribution	   of	  
lobectomies	   according	   to	   site	   was	   similar	   in	   the	   propensity	   score	  matched	   group,	   in	   particular	  
upper	   lobectomies	   appeared	   in	   similar	   proportions	   in	   the	   two	   groups	   (see	   table	   1).	   Pathologic	  
diagnosis	   resulted	  Adenocarcinoma	   in	  56	  cases,	  Squamous	  Cell	  Carcinoma	   in	  27	  cases,	   large	  cell	  
neuroendocrine	   cancer	   in	   2	   cases	   and	   adenosquamous	   carcinoma	   in	  one	   case.	   Pathologic	   stage	  
was	  Ia	  in	  24	  patients,	  Ib	  in	  37	  patients,	  IIa	  (N1)	  in	  17	  patients,	  IIb	  due	  to	  multifocal	  neoplasia	  within	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Surgical	  performance	  and	  short-­‐term	  outcomes	  
Operative	  time	  resulted	  168	  minutes	  (range:	  110	  –	  308)	  for	  robotic	  lobectomy	  and	  112	  (range:	  108	  
–	  188)	  for	  open	   lobectomy	  (p	  <0.001).	  Operative	  time	  encompassed	  docking	  time	  (mean	  6	  ±	  3.2	  
minutes).	  Median	  number	  of	  lymph	  nodes	  removed	  was	  21	  (range	  6	  –	  33)	  in	  the	  robotic	  group	  and	  
19	  (range	  5	  –	  38)	  in	  the	  thoracotomic	  group	  (p	  =	  0.752).	  Number	  of	  N1	  and	  N2	  nodes	  were	  similar	  
between	   RL	   and	   OL	   (9	   vs	   7	   and	   11	   vs	   13	   respectively;	   p	   =	   0.571	   and	   p	   =	   0.653	   respectively).	  
Interlobar	  and	  Lobar	  lymph	  nodes	  (stations	  11-­‐12)	  were	  also	  harvested	  in	  similar	  number	  between	  
the	  two	  groups	  (median	  number	  of	  3	  nodes	   in	  both	  groups).	  Nodal	  upstaging	  rate	  was	  higher	   in	  
the	  robotic	  group,	  although	  this	  difference	  didn’t	   reach	  statistical	   significance	   (21/90	  patients	   in	  
the	  RL	  group	  and	  28/180	  patients	  in	  the	  OL	  group;	  p	  =	  0.061).	  Resection	  margins	  resulted	  negative	  
in	  all	  patients.	  	  
Postoperative	  complications	  are	  showed	   in	  Table	  2.	  The	  robotic	  group	  presented	  a	   lower	  
incidence	  of	  delayed	  (not-­‐intraoperative)	  emothorax	  and	  postoperative	  pneumonia	  (p	  =	  0.050	  and	  
p	   =	   0.049).	   Furthermore,	   the	   patients	   in	   the	   robotic	   group	   presented	   lower	   rate	   of	   atelectasis	  
needing	  bronchoscopy	  (p	  =	  0.026).	  Minor	  complications	  rate	  was	  lower	  in	  the	  robotic	  group	  (p	  =	  
0.02).	  On	  the	  other	  hand,	   incidence	  of	  prolonged	  air	   leak	  resulted	  similar	   in	  the	  two	  groups	  (p	  =	  
0.877).	  Pain	  perception,	  assessed	  with	  VNRS	  scale,	  was	  significantly	  lower	  in	  the	  robotic	  group	  at	  
three	  days	  and	  at	   three	  weeks	   (p	  =	  0.023	  and	  p	  =	  0.015).	  Chest	   tube	  removal	   time	  were	  similar	  
between	  the	  two	  procedures	  (3	  days,	  range	  2	  –	  18	  days	  in	  the	  robotic	  group;	  5	  days,	  range	  3	  –	  16	  
days	  for	  the	  thoracotomy	  group;	  p	  =	  0.671).	  Also	  post-­‐operative	  hospitalization	  time	  was	  similar	  
between	  the	  two	  groups	  (4	  days,	  range	  3	  –	  10	  and	  5	  days,	  range	  4	  –	  34;	  p	  =	  0.351).	  Patients	  were	  
discharged	  with	  chest	  tube	  connected	  to	  an	  Heimlich	  valve	  in	  4	  cases	  after	  RL	  and	  7	  cases	  after	  OL	  
(	  p	  =	  0.451).	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Mid-­‐term	  outcomes	  and	  quality	  of	  life	  evaluation	  
Late	   complications	   were	   evaluated	   after	   one	   month	   and	   then	   five	   months	   from	   the	  
procedure	   (as	   part	   of	   SF	   12	   evaluation	   visit).	   Follow	   up	   information	   was	   complete	   in	   94%	   of	  
patients.	  The	  main	  complaint	  was	  persistent	  pain	  (18	  cases	  in	  the	  thoracotomy	  group	  and	  2	  cases	  
in	  the	  robotic	  group;	  p	  =	  0.020)	  Patients	   from	  the	  RL	  group	  experienced	  faster	  return	  to	  normal	  
activity	  than	  OL	  group	  (16	  days,	  range	  11	  –	  31	  and	  29	  days,	  range	  21	  –	  40;	  p	  =	  0.03).	  In	  particular	  
return	  to	  preoperative	  working	  activity	  level	  was	  >28	  days	  in	  4	  cases	  in	  the	  RL	  group	  and	  29	  cases	  
in	  the	  OL	  group	  (p	  =	  0.007).	  
SF	  12	  survey	  evidenced	  a	  better	  average	  mental	  and	  physical	  health	  perception	  at	  4	  weeks	  
postoperatively	   in	   patients	   who	   underwent	   the	   RL	   relative	   to	   patients	   who	   underwent	   an	   OL	  
(Mental:	  56.2	  vs	  39;	  p	  =	  0.047;	  Physical	  53.8	  vs	  32.1;	  p	  =	  0.020).	  Both	  mental	  and	  physical	  health	  
perception	  maintained	  a	  trend	  toward	  well-­‐being	  in	  the	  RL	  group	  after	  five	  months;	  anyway,	  the	  
difference	  in	  SF	  12	  scores	  did	  not	  reach	  statistical	  significance.	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DISCUSSION	  
	  
In	  2008,	  Melfi	  et	  al.	  reported	  a	  retrospective	  evaluation	  on	  a	  large	  series	  of	  robot	  assisted	  
lobectomies	  using	  a	   three	  arm	  robotic	  device	   [12].	  With	   the	  development	  of	  a	   four-­‐arm	  device,	  
the	  technique	  has	  been	  slightly	  modified,	  allowing	  a	  totally	  endoscopic	  approach	  with	  encouraging	  
results	   [13].	   The	   new	   device	   brought	   a	   standardization	   of	   the	   technique	   (optimization	   of	   port	  
mapping,	   identification	  of	   the	  more	   suitable	   instruments,	   and	  definition	  of	   the	  more	   rapid	   step	  
sequence	   of	   the	   procedure).	   We	   decided	   to	   compare	   the	   robotic	   technique	   to	   the	   standard	  
approach	   on	   clinical	   stage	   I	   NSCLC	   to	   better	   identify	   differences	   and	   avoid	   biases	   derived	   from	  
more	  advanced	   stages,	   such	  as	  preoperative	   chemotherapy,	   larger	   lesions	   (>5	   cm),	  or	  extensive	  
lymphadenopathies	   that	   could	   modify	   standard	   surgical	   strategy.	   Propensity	   score	   matching	  
allowed	  us	  to	  perform	  a	  comparison	  of	  the	  two	  methods,	  given	  the	  non-­‐randomized	  nature	  of	  the	  
technique.	  When	  evaluating	  our	  outcomes,	  operative	  time	  was	  longer	  in	  the	  RL	  group.	  However,	  
from	   the	   beginning	   of	   the	   robotic	   program,	   a	   progressive	   shortening	   of	   the	   procedures	   was	  
observed.	   In	   the	  study	  period	   (three	  years),	  median	  operative	   time	  resulted	  168	  minutes	   (110	  –	  
308	  minutes),	  while	  the	  procedures	  performed	  with	  the	  three	  arm	  robotic	  device	  lasted	  237	  ±	  66.9	  
minutes,	   as	   previously	   reported	   [13].	   The	   reduction	   of	   operative	   time	   resulted	   from	   dedicated	  
training	  of	   personnel	   operating	   in	   the	   surgical	   theatre	   (surgeon,	   nurses,	   and	   anaesthesiologists)	  
and	   improvement	   of	   instrumentation.	   Lymph	   nodal	   dissection	   harvested	   a	   similar	   number	   of	  
lymph	  nodes	   in	   the	   two	  groups.	  Veronesi	   et	   al	   [7]	   reported	  a	   similar	   result	   in	   a	   series	  of	   54	  RL	  
compared	  to	  54	  OLs.	  In	  their	  study	  population,	  lymphadenectomy	  retrieved	  a	  median	  of	  17	  lymph	  
nodes	   (range	   4-­‐30)	   in	   the	   RL	   group	   and	   18	   (range	   4-­‐27)	   in	   the	   OL	   group.	   Cerfolio	   et	   al.	   [14]	  
reported	   a	  median	   of	   11	   N2	   and	   5	   N1	   lymph	   nodes	   in	   course	   of	   106	   consecutive	   RLs	   with	   no	  
differences	   when	   compared	   to	   a	   propensity	   score	   matched	   group	   of	   318	   OLs.	   The	   efficacy	   of	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lymphadenectomy	   during	   RL	   is	   related	   to	   the	   powerful	   vision	   and	   manipulation	   capacity,	   in	  
particular	  when	  removing	  N1	  lymph	  nodes,	  which	  need	  careful	  dissection	  from	  hilar	  structures.	  
When	   analysing	   the	   complication	   rate,	   we	   found	   a	   similar	   incidence	   of	   major	  
complications,	   according	   to	   the	   Clavien-­‐Dindo	   classification.	   However,	   the	   incidence	   of	   post-­‐
operative	  hemothorax	  and	  pneumonia	  resulted	  lower	  in	  the	  RL	  group.	  This	  fact	  should	  be	  related	  
to	  minor	  amount	  of	  blood	  loss	  in	  the	  robotic	  group,	  as	  suggested	  by	  the	  minor	  number	  of	  blood	  
transfusion	  after	  RL,	  and	  minor	  pain	  leading	  to	  more	  appropriate	  coughing	  and	  faster	  respiratory	  
rehabilitation.	  Both	  those	  factors	  probably	  lead	  to	  a	  limited	  incidence	  of	  Atrial	  Fibrillation	  in	  the	  RL	  
group,	  a	  common	  complication	  of	  major	  lung	  surgery.	  	  Incidence	  of	  prolonged	  air	  leak	  was	  similar,	  
this	  data	  may	  derive	  from	  a	  similar	  incidence	  of	  subclinical	  COPD	  in	  the	  two	  groups.	  	  
The	  main	  outcomes	  were	  related	  to	  pain	  perception	  and	  quality	  of	  life	  after	  surgery.	  Pain	  
perception	  was	  significantly	  lower	  in	  the	  RL	  group,	  enhancing	  patient’s	  recovery	  in-­‐hospital	  and	  at	  
home.	   RL	   group	   showed	   a	   trend	   toward	   shorter	   hospitalization,	   even	   if	   this	   difference	   did	   not	  
reach	   statistical	   significance.	   This	   fact	   should	   be	   related	   to	   the	   lower	   incidence	   of	   minor	  
complications	   (in	   particular	   supraventricular	   arrhythmia,	   atelectasis,	   surgical	   access	   hematoma/	  
infection	  and	  pain).	  Other	  authors	  observed	  a	   shorter	  hospitalization	  after	  RL:	  median	  of	  2	  vs	  4	  
days	  (p	  =	  0.01)	  [11],	  4	  vs	  6	  days	  (p	  =	  0.02)	  [7].	  	  In	  particular,	  Cerfolio	  et	  al.	  [14]	  reported	  a	  shorter	  
drainage	  time	  after	  RL	  (1.5	  days	  vs	  3	  days).	  We	  did	  not	  find	  a	  statistically	  significant	  difference	  in	  
drainage	  time	  between	  the	  two	  groups,	  probably	  due	  to	  similar	  air	  leak	  duration.	  As	  far	  as	  quality	  
of	  life	  is	  concerned,	  after	  RL	  patients	  experienced	  both	  physical	  and	  mental	  recovery	  in	  a	  shorter	  
time.	   In	  particular,	  our	  analysis	   focused	  on	   the	   incidence	  of	   chronic	  pain,	   and	   its	   impairment	  of	  
quality	  of	  life.	  When	  compared	  to	  thoracotomy,	  a	  robotic	  approach	  seems	  to	  limit	  the	  degree	  of	  
intercostal	   neuropathy	  with	   a	   limited	   need	   for	   pharmacologic	   treatment	   and	   limited	   impact	   on	  
quality	  of	  life	  and	  working	  activity.	  In	  this	  study,	  quality	  of	  life	  was	  assessed	  by	  SF	  12	  survey.	  The	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main	  limit	  of	  this	  observation	  is	  based	  largely	  on	  its	  subjectivity.	  However,	  the	  results	  underlined	  
the	  possibility	  of	  a	  faster	  recovery	  after	  RL,	  when	  compared	  to	  standard	  approach.	  This	  brought	  a	  
gain	   in	  working	  days	   in	   the	  portion	  of	  population	   in	   the	  active	  age.	  The	  next	   step	  would	  be	   the	  
evaluation	   of	   the	   robotic	   approach	   in	   comparison	   to	   VATS	   lobectomy	   (VL).	   Stephens	   et	   al.	   [15]	  
evidenced	   that	   patients	   undergoing	   VATS	   had	   less	   perioperative	   morbidity	   compared	   with	  
matched	   OL	   controls.	   Regional	   lymphadenectomy,	   nodal	   upstaging,	   overall	   and	   disease-­‐free	  
survival	  were	  similar	  between	  VL	  and	  OL	  groups.	  On	  the	  other	  hand,	  Faivar	  et	  al.	   [16]	  evaluated	  
the	  results	  of	  181	  RL	  and	  compared	  the	  outcomes	  of	  OL	  and	  VL	  as	  reported	  in	  the	  STS	  database	  
(respectively	  5913	  and	  4612	  procedures).	  They	  evidenced	  a	  minor	  morbidity	  and	  mortality	  in	  their	  
RL	   cohort,	   with	   shorter	   hospitalization	   after	   robotic	   approach	   when	   compared	   to	   OL	   and	   VL.	  
However,	   further	   studies	   are	   needed	   to	   compare	   minimally	   invasive	   approaches.	   In	   order	   to	  
ensure	   adequate	   comparison,	   VATS	   lobectomy	   and	   Robot	   Assisted	   lobectomy	   should	   be	  
performed	  in	  the	  same	  period	  of	  time	  with	  a	  state-­‐of-­‐the-­‐art	  technology	  and	  skills	  in	  both	  cases,	  
and	  possibly	  in	  a	  randomized	  fashion.	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CONCLUSIONS	  
Robotic-­‐assisted	   lobectomy	  with	   lymph	  node	  dissection	  for	  clinical	  stage	   I	   lung	  cancer	  proved	  to	  
be	   equal	   to	   open	   lobectomy	   in	   terms	   of	   surgical	   performance.	   When	   directly	   compared	   to	  
thoracotomy,	   the	   minimally	   invasive	   approach	   allows	   a	   faster	   recovery	   with	   a	   long	   lasting	  
limitation	  of	  pain	  perception,	  improvement	  of	  quality	  of	  life	  and	  faster	  return	  to	  the	  preoperative	  
activity	  level,	  when	  compared	  to	  the	  traditional	  approach.	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Upper Lobes (%) 61 57 0.712 
 
Table 1. Patients’ characteristics. 
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Robotic Assisted Lobectomy 
(N = 86) 
Open Lobectomy 
(N = 160) 
P value 
Number of lymph nodes removed (median, 
range) 1 
21 (6 – 34) 19 (5 – 38) 0.752 
Operative Time (min; median, range) 2 168 (110-308) 112 (108 – 188) <0.001 




• Broncho-pleural fistula 
• Major cardiovascular event 
• ARDS 

























Minor Complications 3  
• Atrial fibrillation 
• Prolonged air leak 













Need for Blood transfusion 4 18 0.005 
Drainage time (Days, median, range) 3 (2 – 18) 5 (3 – 19) 0.671 
Days from intervention to discharge (Days, 
median, range) 
4 (3 – 10) 6 (4 – 34) 0.351 
Pain Perception (Verbal Numeric Rating 
Scale, median, range) 4 
• First three days 
• First three weeks 
 
 
3 (1 – 6) 
2 (1 – 4) 
 
 
7 (4 – 9) 





Late Complications (>1 month) 
• Persistent Pain (#) 
• Thoracotomy revision 













Return to working  activity >28 days 5 
 



















Table 2. Surgical performance and outcomes. 
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Notes 
1 Lymphadenectomy included station 4R, 7, 10R, 8, 9 on the right and station 5, 6, 7, 9, 10L on the left. 
2 From skin incision to skin closure. Included the docking time of the Da Vinci Surgical Chart. 
3 Complication magnitude was defined according to Clavien – Dindo Classification [14]. Minor 
complication requires no further or minimal treatment. Major complication requires surgical, radiologic, 
endoscopic intervention (grade III) or intensive care unit management and life support (grade IV).  
4 0 = No Pain, 1 – 3 = Mild Pain (nagging, annoying, interfering little with Activities of Daily Living ADLs), 4 
– 6 = Moderate Pain (interferes significantly with ADLs), 7 – 10 = Severe Pain (disabling; unable to 
perform ADLs). 
5 When applicable (only patient in working active age). 
6 Short Form Health Survey (SF 12) method [15]. 
	   21	  
	  
Figure	  1.	  Port	  placement.	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